OTC •
Healthcare •
Drug Manufacturers - Specialty & Generic •
Quote as of 05/06/2026
Company Profile
IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
ExchangeOTC
Market Capitalization4,004.29 mln
Float108 mln
Earnings Date08/06/2026
EPS
3.62
Solid
P / E
10.83
Fair value
Piotroski F-Score
5
/ 9
Neutral
Beneish M-Score
-2.48
Borderline
Relative Strength
89
/ 100
Strongly outperforming
Debt / Equity
0.62
Moderate leverage
Business Description
Founded in 1978 and based in London, Hikma Pharmaceuticals is a global medicine company that makes and sells a wide range of drugs across multiple markets, including the United States, Europe, and the Middle East and North Africa. Its products cover many treatment areas such as cancer care, breathing conditions, and pain relief, and come in forms ranging from tablets and creams to liquids and injections. Hikma serves both hospitals and retail pharmacies through its three business divisions, which focus on injectable medicines, branded drugs, and general prescription products.
